Mediherbs Research Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 16-11-2024
- Paid Up Capital ₹ 0.30 M
as on 16-11-2024
- Company Age 5 Year, 22 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.90 Cr
as on 16-11-2024
- Revenue 13.71%
(FY 2023)
- Profit -184.00%
(FY 2023)
- Ebitda -21.19%
(FY 2023)
- Net Worth -48.90%
(FY 2023)
- Total Assets 17.38%
(FY 2023)
About Mediherbs Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹4.90 Cr.
Anjali Goel, Nidhi Goel, Tarun Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290GJ2019PTC111116
- Company No.
111116
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2019
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mediherbs Research?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjali Goel  | Director | 02-Dec-2019 | Current |
| Nidhi Goel | Director | 02-Dec-2019 | Current |
| Tarun Sharma | Director | 18-Aug-2020 | Current |
| Bhaskar Goel | Director | 02-Dec-2019 | Current |
Financial Performance of Mediherbs Research.
Mediherbs Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.71% increase. The company also saw a substantial fall in profitability, with a 184% decrease in profit. The company's net worth observed a substantial decline by a decrease of 48.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediherbs Research?
In 2023, Mediherbs Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Homeonest India Private LimitedActive 18 years 7 monthsAnjali Goel, Nidhi Goel and 1 more are mutual person
Avon Assisstance Private LimitedActive 9 years 7 monthsAnjali Goel and Nidhi Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Sep 2023 | ₹2.05 Cr | Open |
Others Creation Date: 29 Jul 2022 | ₹3.08 M | Open |
Others Creation Date: 13 Jul 2021 | ₹1.55 Cr | Open |
How Many Employees Work at Mediherbs Research?
Unlock and access historical data on people associated with Mediherbs Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediherbs Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediherbs Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
